SS, B., SR, K., A, U., & V, N. (2025). Computational Insights into Papaveroline as an In Silico Drug Candidate for Alzheimer's Disease via Fyn Tyrosine Kinase Inhibition. Molecular biotechnology, 67(7), 2743. https://doi.org/10.1007/s12033-024-01236-0
Chicago Style (17th ed.) CitationSS, Bhat, Kulkarni SR, Uttarkar A, and Niranjan V. "Computational Insights into Papaveroline as an In Silico Drug Candidate for Alzheimer's Disease via Fyn Tyrosine Kinase Inhibition." Molecular Biotechnology 67, no. 7 (2025): 2743. https://doi.org/10.1007/s12033-024-01236-0.
MLA (9th ed.) CitationSS, Bhat, et al. "Computational Insights into Papaveroline as an In Silico Drug Candidate for Alzheimer's Disease via Fyn Tyrosine Kinase Inhibition." Molecular Biotechnology, vol. 67, no. 7, 2025, p. 2743, https://doi.org/10.1007/s12033-024-01236-0.